Human GUCY2C-targeted chimeric antigen receptor (CAR)-expressing T cells eliminate colorectal cancer metastases

Overview of attention for article published in Cancer Immunology Research, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 1,945)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 54 news outlets
blogs: 1 blog
twitter: 14 X users

patent: 18 patents
googleplus: 1 Google+ user
reddit: 1 Redditor

Readers on

mendeley: 157 Mendeley

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 81,062 followers.

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. - PubMed - NCBI https://t.co/88X1oHXbwy

Researchers at Bluebird Bio and Thomas Jefferson University have reported a CAR-T-based immunotherapy that successfully kills tumors and prevents metastatic growth, now in final preclinical tests before human trials. https://t.co/mEFKGQpcXp

#Cancer #colorectal: chez la #souris la thérapie cellulaire #CAR-T à biomarqueur GUCY2C permet d'éliminer les #tumeurs et de prévenir les #métastases https://t.co/tT5th0gBT8

A CAR-T-based immunotherapy in mice successfully kills tumors and prevents metastatic growth, in final preclinical tests before human trials. https://t.co/CuO42lBiav #Cancer

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.